Patients with risk factors have higher plasma levels of lysophosphatidic acid: a promising surrogate marker for blood platelet activation.

Yao, Cun-Shan; Yan, Shu-Gui; Gao, Lian-Sheng; Sun, Zhen-Rong; Liu, Feng; Jiang, Bo; Wang, Hai-Bin; Wu, Qi-Zhuan

Yao, Cun-Shan; Yan, Shu-Gui; Gao, Lian-Sheng; Sun, Zhen-Rong; Liu, Feng; Jiang, Bo; Wang, Hai-Bin; Wu, Qi-Zhuan.

Afiliação

Yao CS; aDepartment of Neurology, First Affiliated Hospital of Chinese Army General Hospital, Beijing bDepartment of Internal Medicine, People's Hospital of DongChang District, Tonghua City, Jilin Province cDepartment of Internal Medicine, 8th Hospital of Shijiazhuang, Shijiazhuang, Hebei Province dDepartment of Neurology, People's Hospital of Rui-Cheng County, RuiCheng County, Shanxi Province eDepartment of Neurology, Peking University First Hospital, Beijing, China.

Blood Coagul Fibrinolysis ; 25(4): 322-5, 2014 Jun.

Article em En | MEDLINE | ID: mdl-24346355

Assuntos

Aspirina/administração & dosagem; Plaquetas/efeitos dos fármacos; Plaquetas/metabolismo; Lisofosfolipídeos/sangue; Ativação Plaquetária/fisiologia; Biomarcadores/sangue; Estudos Transversais; Feminino; Humanos; Hiperlipidemias/sangue; Hipertensão/sangue; Masculino; Pessoa de Meia-Idade; Projetos Piloto; Fatores de Risco

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Plaquetas / Lisofosfolipídeos / Ativação Plaquetária / Aspirina Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google